← All indications
Polycythemia
An increase in the total red cell mass of the blood. (Dorland, 27th ed)
Drugs by status
Approved for this indication (2)
Phase 4 trials (1)
Phase 3 trials (2)
Phase 2 trials (4)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (28)
- Incyte
- Celgene
- Roche
- Gilead Sciences
- AOP Orphan Pharmaceuticals AG
- CTI BioPharma
- Constellation Pharmaceuticals
- Sierra Oncology, Inc.
- National Cancer Institute (NCI)
- National Cancer Institute, France
- Baylor University
- University of London
- Queen's University, Belfast
- RWTH Aachen University
- University of Southern Denmark
- University of Birmingham
- Mayo Clinic
- Icahn School of Medicine at Mount Sinai
- University of Vienna
- Medical University of Vienna
- Mario Negri Institute
- University of Texas at Houston
- Myeloproliferative Disorders Research Consoritum
- University of Brescia
- Agenzia Italiana del Farmaco
- Assistance Publique - Hôpitaux de Paris
- MPN Voice
- PharmaEssentia Corp.
Organization Involved with Phase 2 Indications (52)
- S*BIO
- Jazz Pharmaceuticals
- YM Biosciences
- Cephalon
- Bristol-Myers Squibb
- OSI Pharmaceuticals
- Pfizer
- Sanofi
- Geron Corporation
- Italfarmaco
- Karyopharm Therapeutics Inc
- Promedior, Inc.
- Protagonist Therapeutics
- Imago BioSciences
- National Heart, Lung, and Blood Institute (NHLBI)
- Cornell University
- Harvard University
- Eastern Cooperative Oncology Group
- University of Washington
- Johns Hopkins University
- McGill University
- Melbourne Health
- PV-Nord
- Stanford University
- Swiss Group for Clinical Cancer Research
- Thomas Jefferson University
- University of Miami
- University of Milan
- University of Oklahoma
- University of Ottawa
- +22 more
Organization Involved with Phase 1 Indications (19)
- Millennium Pharmaceuticals
- AstraZeneca
- Eli Lilly
- Exelixis
- Sponsor GmbH
- Forbius
- University of Pittsburgh
- AIDS Malignancy Consortium
- Northwestern University
- University of Maryland
- Vanderbilt University
- Institut Gustave Roussy
- City of Hope National Medical Center
- University of Texas, San Antonio
- University of Illinois at Chicago
- The Leukemia and Lymphoma Society
- Samus Therapeutics
- The University of Texas, Dallas
- Myeloproliferative Neoplasm Research Consortium (MPN-RC)
Organization Involved with Other Experimental Indications (1)